Literature DB >> 29143474

Chronic intestinal pseudo-obstruction: Progress in management?

G Di Nardo1,2, T B Karunaratne3, S Frediani4, R De Giorgio5.   

Abstract

Chronic intestinal pseudo-obstruction (CIPO) is a severe form of gastrointestinal dysmotility (often due to derangement of the innervation/smooth muscle/interstitial cells of Cajal) with recurrent episodes of intestinal subocclusion mimicking a mechanical obstruction. Because of its complexity and heterogeneity, CIPO is often misdiagnosed or remains unrecognized until advanced stages. Management is a critical aspect in CIPO patient care. So far, most prokinetic drugs have not proven efficacy in restoring intestinal propulsion, thus nutritional support, fluid/electrolyte replacement, and antibiotics are the mainstay of treatment. In this issue of the journal, Ohkubo et al showed promising data indicating that percutaneous endoscopic gastro-jejunostomy (PEG-J) can be proposed as a measure for intestinal decompression, thereby improving CIPO-associated abdominal symptoms, including pain. In addition to a concise update of clinical and diagnostic features, the present minireview tackles management options, with a major emphasis on PEG-J, for CIPO patients.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  chronic intestinal pseudo-obstruction; clinical manifestations; diagnosis; intestinal decompression; percutaneous endoscopic gastro-jejunostomy

Mesh:

Year:  2017        PMID: 29143474     DOI: 10.1111/nmo.13231

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  9 in total

1.  Anti-Hu-Mediated Paraneoplastic Chronic Intestinal Pseudo-Obstruction Arising From Small Cell Prostate Cancer.

Authors:  Javier A Cerra-Franco; Carlos Fernandez-Cruz; Rodolfo Estremera-Marcial; Hendrick Pagan-Torres; Jaime Martinez-Souss; Doris H Toro
Journal:  ACG Case Rep J       Date:  2019-07-03

Review 2.  Small Bowel Dysmotility, Pseudoobstruction, and Functional Correlation with Histopathology: Lessons Learned.

Authors:  Zorisadday Gonzalez; Richard McCallum
Journal:  Curr Gastroenterol Rep       Date:  2020-02-20

3.  Challenges in management and prognosis of pediatric intestinal pseudo-obstruction.

Authors:  Özlem Boybeyi Türer; Tutku Soyer; Hasan Özen; Umut Ece Arslan; İbrahim Karnak; Feridun Cahit Tanyel
Journal:  Turk J Gastroenterol       Date:  2020-08       Impact factor: 1.852

Review 4.  [Interdisciplinary endoscopy in children].

Authors:  Kianusch Tafazzoli; Martina Kohl; Martha Kirstein; Lutz Wünsch
Journal:  Chirurg       Date:  2021-01-27       Impact factor: 0.955

5.  Chronic intestinal pseudo-obstruction with pneumatosis cystoides intestinalis in a patient with systemic sclerosis: A case report.

Authors:  Yuki Mitsuyoshi; Kazuki Takakura; Takashi Kobayashi; Nanako Ogawa; Toshiyuki Sakurai; Masanori Nakano; Taro Ukichi; Yozo Ishiuji; Yuichi Torisu; Masayuki Saruta
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

Review 6.  Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment.

Authors:  Luísa Leite Barros; Alberto Queiroz Farias; Ali Rezaie
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

Review 7.  Infection Prevention and Management in Pediatric Short Bowel Syndrome.

Authors:  Laura Merras-Salmio; Mikko P Pakarinen
Journal:  Front Pediatr       Date:  2022-06-30       Impact factor: 3.569

8.  Fasted and fed small bowel motility patterns at cine-MRI in chronic intestinal pseudo-obstruction.

Authors:  Kyra L van Rijn; Albert J Bredenoord; André J P M Smout; Gerd Bouma; Jeroen A W Tielbeek; Karin Horsthuis; Jaap Stoker; Catharina S de Jonge
Journal:  Neurogastroenterol Motil       Date:  2020-12-27       Impact factor: 3.598

9.  Motility index measured by magnetic resonance enterography is associated with sex and mural thickness.

Authors:  Sven Månsson; Olle Ekberg; Bodil Ohlsson
Journal:  World J Gastroenterol       Date:  2020-09-28       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.